Cargando…

Intracranial Metastatic Disease: Present Challenges, Future Opportunities

Intracranial metastatic disease (IMD) is a prevalent complication of cancer that significantly limits patient survival and quality of life. Over the past half-century, our understanding of the epidemiology and pathogenesis of IMD has improved and enabled the development of surveillance and treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Alyssa Y., Gaebe, Karolina, Jerzak, Katarzyna J., Cheema, Parneet K., Sahgal, Arjun, Das, Sunit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940535/ https://www.ncbi.nlm.nih.gov/pubmed/35330715 http://dx.doi.org/10.3389/fonc.2022.855182

Ejemplares similares

Editorial: Contemporary Management of Intracranial Metastatic Disease
por: Das, Sunit, et al.
Publicado: (2019)

Clinical Biomarkers for Early Identification of Patients with Intracranial Metastatic Disease
por: Gaebe, Karolina, et al.
Publicado: (2021)

Association of Brain Metastases With Survival in Patients With Limited or Stable Extracranial Disease: A Systematic Review and Meta-analysis
por: Li, Alyssa Y., et al.
Publicado: (2023)

HER2-targeted therapy prolongs survival in patients with HER2-positive breast cancer and intracranial metastatic disease: a systematic review and meta-analysis
por: Erickson, Anders W, et al.
Publicado: (2020)

The Impact of Targeted Therapy on Intracranial Metastatic Disease Incidence and Survival
por: Erickson, Anders W., et al.
Publicado: (2019)

Commentary: Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial
por: Das, Sunit, et al.
Publicado: (2020)

THER-01. Targeted therapy and intracranial metastatic disease: a population-based retrospective cohort study
por: Erickson, Anders, et al.
Publicado: (2021)

Dual- versus single-agent HER2 inhibition and incidence of intracranial metastatic disease: a systematic review and meta-analysis
por: Erickson, Anders Wilder, et al.
Publicado: (2021)

Incidence and real-world burden of brain metastases from solid tumors and hematologic malignancies in Ontario: a population-based study
por: Habbous, Steven, et al.
Publicado: (2020)

PD-L1 expression in breast cancer brain metastases
por: Chehade, Rania, et al.
Publicado: (2022)

Karnofsky Performance Status (KPS) ≤60 Is Strongly Associated With Shorter Brain-Specific Progression-Free Survival Among Patients With Metastatic Breast Cancer With Brain Metastases
por: Freeman, Mark, et al.
Publicado: (2022)

Alpha Thalassemia/Mental Retardation Syndrome X-Linked, the Alternative Lengthening of Telomere Phenotype, and Gliomagenesis: Current Understandings and Future Potential
por: He, Jenny, et al.
Publicado: (2018)

Targeting Molecular Pathways in Intracranial Metastatic Disease
por: Venur, Vyshak Alva, et al.
Publicado: (2019)

Analysis of Rates of Brain Metastases and Association With Breast Cancer Subtypes in Ontario, Canada
por: Wang, Xin Ye, et al.
Publicado: (2022)

Turning “Cold” Into “Hot” Tumors—Opportunities and Challenges for Radio-Immunotherapy Against Primary and Metastatic Brain Cancers
por: Sevenich, Lisa
Publicado: (2019)

Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases
por: Soliman, Hany, et al.
Publicado: (2016)

Management of Intracranial Metastatic Disease With Laser Interstitial Thermal Therapy
por: Salehi, Afshin, et al.
Publicado: (2018)

Editorial: Biology-Driven Targeted Therapy of Pediatric Soft-Tissue and Bone Tumors: Current Opportunities and Future Challenges
por: Grünewald, Thomas G. P., et al.
Publicado: (2016)

Management of HER2-Positive Early Breast Cancer in Italy: A Maze Presenting Opportunities and Challenges
por: Stucci, Luigia Stefania, et al.
Publicado: (2022)

04. ASSESSMENT OF EFFICACY AND SAFETY OF OSIMERTINIB FOR PATIENTS WITH INTRACRANIAL METASTATIC DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Erickson, Anders, et al.
Publicado: (2020)

Editorial: Radioimmunotherapy—Translational Opportunities and Challenges
por: Gaipl, Udo S., et al.
Publicado: (2020)

Biomarkers for prostate cancer: present challenges and future opportunities
por: Sharma, Pranav, et al.
Publicado: (2015)

Procarbazine, CCNU and vincristine (PCV) versus temozolomide chemotherapy for patients with low-grade glioma: a systematic review
por: Hafazalla, Karim, et al.
Publicado: (2018)

Assessment of Effectiveness and Safety of Osimertinib for Patients With Intracranial Metastatic Disease: A Systematic Review and Meta-analysis
por: Erickson, Anders W., et al.
Publicado: (2020)

Ferroptosis: A potential opportunity for intervention of pre-metastatic niche
por: Zhuo, Shenghua, et al.
Publicado: (2022)

Opportunities and Challenges for Successful Use of Bevacizumab in Pediatrics
por: Barone, Amy, et al.
Publicado: (2013)

Opportunities and Challenges of the Human Microbiome in Ovarian Cancer
por: Cheng, Huiyan, et al.
Publicado: (2020)

Challenges and Opportunities Associated With Platelets in Pancreatic Cancer
por: Chen, Zhou, et al.
Publicado: (2022)

Opportunities and Challenges for Gut Microbiota in Acute Leukemia
por: Ma, Tao, et al.
Publicado: (2021)

Extracellular Vesicles and Hepatocellular Carcinoma: Opportunities and Challenges
por: Wang, Juan, et al.
Publicado: (2022)

Ferroptosis in Glioma Immune Microenvironment: Opportunity and Challenge
por: Wang, Kaikai, et al.
Publicado: (2022)

Opportunities and challenges related to ferroptosis in glioma and neuroblastoma
por: Chi, Huizhong, et al.
Publicado: (2023)

UPS: Opportunities and challenges for gastric cancer treatment
por: Yang, Hang, et al.
Publicado: (2023)

Multiple Myeloma Relapse as Intracranial Plasmacytoma: A Rare Presentation
por: Prakash, Amulya, et al.
Publicado: (2020)

Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy
por: Fang, Penny Q., et al.
Publicado: (2021)

Advanced Magnetic Resonance Imaging Techniques in Management of Brain Metastases
por: Mehrabian, Hatef, et al.
Publicado: (2019)

Big Data in Designing Clinical Trials: Opportunities and Challenges
por: Mayo, Charles S., et al.
Publicado: (2017)

Understanding Esophageal Cancer: The Challenges and Opportunities for the Next Decade
por: Yang, Jianjun, et al.
Publicado: (2020)

COVID-19 vaccination in patients with cancer: Opportunities and challenges
por: Al-qaim, Zahraa Haleem, et al.
Publicado: (2022)

Treatment of Residual, Recurrent, or Metastatic Intracranial Hemangiopericytomas With Stereotactic Radiotherapy Using CyberKnife
por: Huang, Lichao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cetrhjpd4iepg8pvkv83qjhboe